{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=25+mg+Proellex", "query": { "intervention": "25 mg Proellex" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 20, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=25+mg+Proellex&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-09T12:22:07.806Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00874302", "title": "Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uterine Fibroids" ], "interventions": [ { "name": "Proellex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 0, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 13, "location_summary": "San Diego, California • Sarasota, Florida • Atlanta, Georgia + 9 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Decatur", "state": "Georgia" }, { "city": "Marrero", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00874302" }, { "nct_id": "NCT00741468", "title": "Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Drug Interactions" ], "interventions": [ { "name": "Proellex", "type": "DRUG" }, { "name": "CYP1A2 probe", "type": "DRUG" }, { "name": "CYP2C9 probe", "type": "DRUG" }, { "name": "CYP2C19 probe", "type": "DRUG" }, { "name": "CYP2D6 probe", "type": "DRUG" }, { "name": "CYP3A4 probe", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "48 Years", "sex": "FEMALE", "summary": "18 Years to 48 Years · Female only" }, "enrollment_count": 18, "start_date": "2008-07", "completion_date": "2008-10", "has_results": true, "last_update_posted_date": "2014-08-22", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 1, "location_summary": "Hackensack, New Jersey", "locations": [ { "city": "Hackensack", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT00741468" }, { "nct_id": "NCT01069120", "title": "Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uterine Fibroids" ], "interventions": [ { "name": "Proellex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 27, "start_date": "2009-04", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2014-08-21", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 4, "location_summary": "Boynton Beach, Florida • Tampa, Florida • Houston, Texas", "locations": [ { "city": "Boynton Beach", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01069120" }, { "nct_id": "NCT00958412", "title": "Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "Proellex®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "48 Years", "sex": "FEMALE", "summary": "18 Years to 48 Years · Female only" }, "enrollment_count": 18, "start_date": "2009-02-28", "completion_date": "2009-08-31", "has_results": true, "last_update_posted_date": "2019-02-12", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 8, "location_summary": "Tucson, Arizona • San Diego, California • San Ramon, California + 4 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "San Ramon", "state": "California" }, { "city": "West Palm Beach", "state": "Florida" }, { "city": "Cary", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00958412" }, { "nct_id": "NCT00702702", "title": "Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uterine Fibroids", "Anemia" ], "interventions": [ { "name": "Proellex 25 mg", "type": "DRUG" }, { "name": "Proellex 50 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 56, "start_date": "2008-06", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2014-08-21", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 30, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Anaheim, California + 21 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00702702" }, { "nct_id": "NCT00749879", "title": "Crossover Study of the Safety and PK Properties of Proellex®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pharmacokinetics" ], "interventions": [ { "name": "Proellex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "34 Years", "sex": "FEMALE", "summary": "18 Years to 34 Years · Female only" }, "enrollment_count": 17, "start_date": "2008-08-11", "completion_date": "2008-10-23", "has_results": true, "last_update_posted_date": "2019-04-29", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00749879" }, { "nct_id": "NCT00853567", "title": "Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Uterine Fibroids" ], "interventions": [ { "name": "Proellex", "type": "DRUG" }, { "name": "placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "48 Years", "sex": "FEMALE", "summary": "18 Years to 48 Years · Female only" }, "enrollment_count": 71, "start_date": "2009-02", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2014-08-21", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 17, "location_summary": "Anaheim, California • Los Angeles, California • Miami, Florida + 10 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853567" }, { "nct_id": "NCT00556075", "title": "Safety and Efficacy Study to Evaluate Proellex in the Treatment of Premenopausal Women With Symptomatic Endometriosis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Endometriosis" ], "interventions": [ { "name": "Proellex 25 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Proellex 50 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "48 Years", "sex": "FEMALE", "summary": "18 Years to 48 Years · Female only" }, "enrollment_count": 67, "start_date": "2007-11", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2014-08-25", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 17, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • San Diego, California + 13 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "San Ramon", "state": "California" }, { "city": "Lake Worth", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00556075" }, { "nct_id": "NCT00958334", "title": "Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Uterine Fibroids" ], "interventions": [ { "name": "Proellex®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "FEMALE", "summary": "18 Years to 50 Years · Female only" }, "enrollment_count": 65, "start_date": "2006-09-07", "completion_date": "2008-10-15", "has_results": true, "last_update_posted_date": "2019-06-18", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 11, "location_summary": "Phoenix, Arizona • San Diego, California • Denver, Colorado + 5 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00958334" }, { "nct_id": "NCT00881608", "title": "Study to Evaluate Menses Induction in Women Administered Proellex", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Amenorrhea" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Proellex", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Repros Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 11, "start_date": "2009-02", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2014-08-25", "last_synced_at": "2026-09-09T12:22:07.806Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00881608" } ] }